
|Articles|August 13, 2008
Viread now also approved to treat hepatitis B
The drug is administered as a once-daily tablet.
Advertisement
The anti-HIV drug Viread (tenofovir disoproxil fumarate, Gilead Sciences) has gained a new indication: to treat chronic hepatitis B in adults. Administered as a once-daily tablet, the
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacies Adapting to IRA-Negotiated Drug Prices Despite Looming Financial Concerns
2
More Than 200 Organizations Denounce Childhood Vaccine Schedule Change
3
Adjunctive Lumateperone Maintains Remission Rates for Major Depressive Disorder
4
Trump Administration Lays Out Great Healthcare Plan for Lower Patient Costs
5










































































































































































































